Israeli Drug Helps Jimmy Carter Beat Cancer
Image by Getty Images
(JTA) — A drug that was researched and tested in Israel has helped former President Jimmy Carter overcome his life-threatening case of melanoma.
Carter announced on Sunday that the four cancerous lesions on his brain were gone and doctors had found no new signs of cancer growth.
He also said that he will continue taking Keytruda, one of a group of new so-called “immunotherapy” drugs, which aim to help a patient’s immune system defeat the spread of cancer. It was researched by Jacob Schachter at the Sheba Medical Center in Ramat Gan, Israel.
Keytruda helps immune system cells identify and destroy tumor cells, which usually pass by them undetected. This bolstering of the immune system is a break from the theory behind chemotherapy, which is designed to destroy cancerous cells but also destroys healthy ones.
Carter, 91, has said that he has experienced no side effects to Keytruda.
“The new drug creates real potential for curing one of the deadliest forms of cancer, at the negligible cost of light and tolerable side effects,” Schachter, a professor and head of the Ella Institute for Melanoma at the Sheba Medical Center, told Ynet last year. “Among doctors, too, the scope of the breakthrough has yet to be digested.”
Carter announced in August that he had stage 4 melanoma that had spread across his body.
However, cancer experts told NBC News that it is not completely clear whether the drug cured Carter on its own, and that advanced forms of the cancer have been known to disappear and return. The former commander-in-chief was also treated with traditional radiation and had a tumor on his liver removed.
It’s our birthday and we’re still celebrating!
We hope you appreciated this article. Before you go, we’d like to ask you to please support the Forward’s independent Jewish news.
This week we celebrate 129 years of the Forward. We’re proud of our origins as a Yiddish print publication serving Jewish immigrants. And we’re just as proud of what we’ve become today: A trusted source of Jewish news and opinion, available digitally to anyone in the world without paywalls or subscriptions.
We’ve helped five generations of American Jews make sense of the news and the world around them — and we aren’t slowing down any time soon.
As a nonprofit newsroom, reader donations make it possible for us to do this work. Support independent, agenda-free Jewish journalism and our board will match your gift in honor of our birthday!
Support our mission to tell the Jewish story fully and fairly.
